[{"NetIncomeLoss_1_Q2_USD":-26382000.0,"DepreciationAndAmortization_2_Q2_USD":1288000.0,"DepreciationAndAmortization_1_Q2_USD":600000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":14041000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":7511000.0,"InterestAndOtherIncome_2_Q2_USD":489000.0,"InterestAndOtherIncome_1_Q2_USD":171000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":30000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-59497000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":150157000.0,"PaymentsToAcquireInvestments_2_Q2_USD":183238000.0,"AssetsCurrent_0_Q2_USD":396281000.0,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.0,"OperatingLeaseExpense_2_Q2_USD":1700000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":5276651.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":5276651.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":241000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":-19000.0,"CommonStockSharesIssued_0_Q2_shares":44403547.0,"Assets_0_Q2_USD":517981000.0,"ShareBasedCompensation_2_Q2_USD":6644000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":9737130.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":150157000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"LitigationSettlementExpense_2_Q2_USD":0.0,"OperatingLeaseExpense_1_Q2_USD":900000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-19000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-57000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":12399000.0,"ShortTermInvestments_0_Q2_USD":197814000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":48997000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":25994000.0,"EarningsPerShareBasic_2_Q2_USD":-1.23,"EarningsPerShareBasic_1_Q2_USD":-0.6,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":41318281.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":43804066.0,"AccountsReceivableNetCurrent_0_Q2_USD":2537000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":210000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":139000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q2_USD":3986000.0,"CommonStockValue_0_Q2_USD":44000.0,"Revenues_2_Q2_USD":12102000.0,"Revenues_1_Q2_USD":7091000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":151830000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":1592000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-50657000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-26382000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-50714000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-26401000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":2119000.0,"OtherAssetsNoncurrent_0_Q2_USD":2745000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":188207000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":119681000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":552459000.0,"Liabilities_0_Q2_USD":119803000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":837000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_0_Q2_USD":170000.0,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"OperatingIncomeLoss_2_Q2_USD":-50936000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q2_USD":3897000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":14471000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q2_USD":4105000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-50447000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-26243000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3944000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-23482000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":41318281.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":43804066.0,"LiabilitiesCurrent_0_Q2_USD":46844000.0,"AccountsPayableCurrent_0_Q2_USD":5405000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":188207000.0,"IncreaseDecreaseInContractWithCustomerAsset_2_Q2_USD":-7500000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":4581000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":631000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_2_Q2_USD":400000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_1_Q2_USD":200000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q2_security":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_2_Q2_USD":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_1_Q2_USD":0.0,"SecurityDeposit_0_Q2_USD":91000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":188377000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":607000.0,"DividendsCommonStock_2_Q2_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":8345000.0,"NetIncomeLoss_2_Q2_USD":-50657000.0,"RestrictedCashNoncurrent_0_Q2_USD":170000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":703000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.6,"CommonStockSharesOutstanding_0_Q2_shares":44403547.0,"OperatingIncomeLoss_1_Q2_USD":-26414000.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_Q2_USD":-671000.0,"IncomeTaxesReceivable_0_Q2_USD":3100000.0,"IncreaseDecreaseInIncomeTaxesReceivable_2_Q2_USD":-704000.0,"IncomeTaxReceivable_0_Q2_USD":3142000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":33761000.0,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":517981000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":4986000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":48900000.0,"IncomeTaxExaminationInterestAccrued_0_Q2_USD":100000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":22816000.0,"OperatingExpenses_2_Q2_USD":63038000.0,"OperatingExpenses_1_Q2_USD":33505000.0,"ProfitLoss_2_Q2_USD":-50657000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":837000.0,"OtherLiabilitiesCurrent_0_Q2_USD":601000.0,"StockholdersEquity_0_Q2_USD":398178000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":72122000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":2934000.0,"LongTermInvestments_0_Q2_USD":110440000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-566000.0,"OperatingLeasesFutureMinimumPaymentsDueInFiveYears_0_Q2_USD":1732000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-154355000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":68851000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":2537000.0,"EarningsPerShareDiluted_2_Q2_USD":-1.23,"OperatingLeasesFutureMinimumPaymentsDue_0_Q2_USD":15312000.0,"Ticker":"NRIX","CIK":"1549595","name":"NURIX THERAPEUTICS, INC.","OfficialName":"Nurix Therapeutics Inc. Common stock","form":"10-Q","period":"20210531","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"593342561.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210713"}]